ZYUS Life Sciences Completes Secured Loan Financing

MT newswire2026/09/01 17:26

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

01:26 PM EDT, 09/01/2026 (MT Newswires) -- ZYUS Life Sciences' (ZYUS.V) wholly-owned subsidiary, ZYUS Life Sciences Inc, completed its secured loan financing and raised gross proceeds of around C$1.9 million, it said after markets closed Monday. The secured loan, completed in nine tranches, has an interest rate of 12% per annum, is prepayable at any time without penalty or premium, and matures six months from the effective date of each loan, said the company. Certain insiders took part in the secured loan for a total of C$845,000, added the company. The company's shares last traded May 6, closing at C$0.495 on the TSX Venture Exchange.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The rise in U.S. Treasury yields and delays in Oracle data centers are dampening AI investment sentiment. Samsung and SK Hynix shares both fell by over 5% in a single day, with their respective stock buyback programs already 85.95% and 66.27% complete, leaving limited upside potential. Currently, the funds waiting to enter the market in Korean brokerage accounts amount to only 101.63 trillion won. The market is focusing on the U.S. PCE data on September 30 and Micron's financial results.

华尔街见闻•2026/09/28 20:16

Ganfeng invests USD 180 million in Lithium Argentina via 6-year convertible note

Bitget•2026/09/28 20:15

Centuri names Michael Christy EVP, group development officer

Bitget•2026/09/28 20:10